Director Share Dealings
December 23, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company")
announces that today Ordinary Shares ("Shares") and American Depository Shares
("ADSs") of the Company, as set out below, have been acquired for the
Non-Executive Directors, being the part of their total fees that are paid in
shares for the period of service from October 1 to December 31, 2013.
Type of Security(1) Number of Shares/ADSs
William Burns Shares 230
Dr. Steven Gillis ADSs 73
Dr. David Ginsburg ADSs 72
David Kappler Shares 214
Susan Kilsby ADSs 56
Anne Minto Shares 272
David Stout ADSs 66
(1) One ADS is equal to three Shares
The Shares and ADSs were acquired on the London Stock Exchange and NASDAQ
respectively at prices of £28.13 per Share and $137.74 per ADS.
This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a)
of the Disclosure and Transparency Rules.
Tony Guthrie
Deputy Company Secretary
For further information please contact:
Investor Relations
Eric Rojas erojas@shire.com +1 781 482 0999
Sarah Elton-Farr seltonfarr@shire.com +44 1256 894157
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty
medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal,
Internal Medicine and Regenerative Medicine and we are developing treatments
for symptomatic conditions treated by specialist physicians in other targeted
therapeutic areas.
www.shire.com
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
Press Release
www.shire.com© 2013 PR Newswire
